Sachs L
Department of Genetics, Weizmann Institute of Science, Rehovot, Israel.
Cancer. 1990 May 15;65(10):2196-206. doi: 10.1002/1097-0142(19900515)65:10<2196::aid-cncr2820651006>3.0.co;2-y.
The establishment of a cell culture system for the clonal development of hematopoietic cells has made it possible to discover the proteins that control growth and differentiation of different hematopoietic cell lineages and the molecular basis of normal and abnormal cell development in blood-forming tissues. A model system with myeloid cells has shown that normal hematopoietic cells require different proteins to induce cell multiplication and cell differentiation, and that a cascade of interactions between proteins determines the correct balance between immature and mature cells in normal development. Gene cloning has shown that there is a family of different genes for these proteins. Normal protein regulators of hematopoiesis can control the abnormal growth of certain types of leukemic cells and suppress malignancy by inducing differentiation to mature nondividing cells. Genetic abnormalities that give rise to malignancy in these leukemic cells can be bypassed and their effects nullified by inducing differentiation, which stops cells from multiplying. These hematopoietic regulatory proteins are active in culture and in vivo and have been used clinically to correct defects in blood cell development. The results provide new approaches to therapy.
用于造血细胞克隆发育的细胞培养系统的建立,使得发现控制不同造血细胞谱系生长和分化的蛋白质以及造血组织中正常和异常细胞发育的分子基础成为可能。一个髓样细胞模型系统表明,正常造血细胞需要不同的蛋白质来诱导细胞增殖和细胞分化,并且蛋白质之间的一系列相互作用决定了正常发育中未成熟细胞和成熟细胞之间的正确平衡。基因克隆表明,这些蛋白质有一个不同基因的家族。正常的造血蛋白调节剂可以控制某些类型白血病细胞的异常生长,并通过诱导分化为成熟的非分裂细胞来抑制恶性肿瘤。通过诱导分化可以绕过这些白血病细胞中导致恶性肿瘤的基因异常并使其影响无效,从而阻止细胞增殖。这些造血调节蛋白在培养和体内均有活性,并已在临床上用于纠正血细胞发育缺陷。这些结果为治疗提供了新方法。